Albert Cho - 01 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: EVP, Strategy
Issuer ticker: XYL
Reported as of: 01 Mar 2026
Net transaction value: +$664,505
SEC form: 4
Accepted by SEC: 03 Mar 2026, 17:05:12 UTC
Prior SEC filing: 06 Mar 2025
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mike Nazario, by power of attorney for Albert Cho

Key filing fact

Albert Cho filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2026.

Key facts

This page summarizes Albert Cho's Form 4 filing for Xylem Inc. (XYL).
9 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 17:05.

Change

Previous filing in this sequence was filed on 06 Mar 2025.
Current net transaction value: +$664,505.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002025025 Primary reporting owner

Cho Albert

Relationship: EVP, Strategy
Address: C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON
Signature: /s/ Mike Nazario, by power of attorney for Albert Cho
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value: $169,093
Shares: +1,311
Change %: +9.3%
Price: $128.98
Shares after: 15,418
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F1, F2

XYL transaction

Common Stock

Award

Transaction value: $139,556
Shares: +1,082
Change %: +7%
Price: $128.98
Shares after: 16,500
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F3

XYL transaction

Common Stock

Award

Transaction value: $94,800
Shares: +735
Change %: +4.5%
Price: $128.98
Shares after: 17,235
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F4

XYL transaction

Common Stock

Award

Transaction value: $75,711
Shares: +587
Change %: +3.4%
Price: $128.98
Shares after: 17,822
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F5

XYL transaction

Common Stock

Award

Transaction value: $0
Shares: +1,042
Change %: +5.8%
Price: $0.000000
Shares after: 18,864
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F6

XYL transaction

Common Stock

Tax liability

Transaction value: $207,658
Shares: -1,610
Change %: -8.5%
Price: $128.98
Shares after: 17,254
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F7

XYL transaction

Common Stock

Tax liability

Transaction value: $38,049
Shares: -295
Change %: -1.7%
Price: $128.98
Shares after: 16,959
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F8

XYL transaction

Common Stock

Tax liability

Transaction value: $47,852
Shares: -371
Change %: -2.2%
Price: $128.98
Shares after: 16,588
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F9

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Non-Qualified Stock Options (Right to Buy)

Award

Transaction value: $478,903
Shares: +3,713
Change %
Price: $128.98
Shares after: 3,713
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,713
Exercise price: $128.98
Footnotes: F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Reflects the acquisition of 1,311 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.

Footnote F2

Includes additional shares due to dividend reinvestment.

Footnote F3

Reflects the acquisition of 1,082 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.

Footnote F4

Reflects the acquisition of 735 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.

Footnote F5

Reflects the acquisition of 587 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.

Footnote F6

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.

Footnote F7

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).

Footnote F8

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).

Footnote F9

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (207) and March 1, 2024 (164) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Footnote F10

Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.